Everything below concerns research chemical. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-01-03. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ in preclinical models |
| Molecular formula | C20H24ClN3O4S | Reported for the parent compound |
| CAS Registry Number | 1379686-30-2 | Common identifier in chemical databases |
| Appearance | Off-white to pale yellow solid | Typical research chemical solid |
| Solubility | Soluble in DMSO and ethanol; low in water | Class: small organic molecule |
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
=== Public safety === Ford came under fire in December 2018 by Ontario Provincial Police (OPP) Deputy Commissioner Brad Blair, who claimed Ford requested the OPP “purchase a large camper-type vehicle ... modified to specifications the premier's office would provide” and keep the costs “off the books.” The vehicle was intended for the premier to use for work, and reportedly was asked to include a swivel chair. The accusation followed on the heels of Ford appointing a longtime family friend to be the next OPP commissioner just days after lowering the requirements for the position. In response to increasing calls for one, Ford has stated he opposes a ban on handguns in Ontario. Ford opposes supervised drug injection sites. The Ford government passed The Protect Ontario Through Safer Streets and Stronger Communities Act, 2025, which introduced several changes, including: more special constables will be able to carry firearms, police will be given more powers to investigate cases of human trafficking, there will be stronger penalties for vehicle theft, more support for victims of human trafficking and violent crime, changes to bail laws, more appointed judges, more funding for community safety programs, and implemented mandatory drug addiction treatment options instead of, or alongside, traditional sentences.
== Research == Mitra's research aims to study the complex biological systems from a “theoretical engineering” perspective. He combines theoretical, computational and experimental approaches and currently understanding how brains work. Professor Mitra initiated the idea of brain-wide mesoscale circuit mapping and founded the Brain Architecture Project, including collaborations with RIKEN Brain Science Institute and Monash University. He has published over 240 research articles in peer-reviewed journals such as Nature, Science, PNAS, PRL with an H-index of 70 and holds thirty-one U.S. patents. He has also co-authored a book titled Observed Brain Dynamics published by the Oxford University Press and has written pieces for Scientific American.
Seizures Syndrome of inappropriate secretion of antidiuretic hormone Blood dyscrasias including: Agranulocytosis Thrombocytopenia Eosinophilia Leukopenia Myocardial infarction Heart block QTc interval prolongation Sudden cardiac death Depression worsening Suicidal ideation
==== Pembrolizumab ==== As of 2019, pembrolizumab, which blocks PD-1, programmed cell death protein 1, has been used via intravenous infusion to treat inoperable or metastatic melanoma, metastatic non-small cell lung cancer (NSCLC) in certain situations, as a second-line treatment for head and neck squamous cell carcinoma (HNSCC), after platinum-based chemotherapy, and for the treatment of adult and pediatric patients with refractory classic Hodgkin's lymphoma (cHL). It is also indicated for certain patients with urothelial carcinoma, stomach cancer and cervical cancer.
Sources: en.wikipedia.org
As a result of the partition of the Korean peninsula by America and the Soviet Union after World War II, and exacerbated by the subsequent Korean War, there is a Demilitarised Zone (DMZ) spanning the de facto border between North and South Korea. The DMZ follows the effective boundaries as of the end of the Korean War in 1953. Similar to the Frontier Closed Area in Hong Kong, this zone and the defence apparatus on both sides of the border serve to curtail unauthorised passage between them. In South Korea, there is an additional fenced-off area between the Civilian Control Line (CCL) and the start of the Demilitarized Zone. The CCL is a line that designates an additional buffer zone to the Demilitarized Zone, located 5 to 20 kilometres (3.1 to 12.4 miles) from the Southern Limit Line of the Demilitarized Zone. Its purpose is to limit and control civilian entry into the area to protect and maintain the security of military facilities and operations near the Demilitarized Zone. The commander of the 8th US Army ordered the creation of the CCL, and it was activated and first became effective in February 1954. The buffer zone that falls south of the Southern Limit Line is called the Civilian Control Zone. Barbed wire fences and manned military guard posts mark the CCL. South Korean soldiers typically accompany tourist buses and cars travelling north of the CCL as armed guards to monitor the civilians as well as to protect them from North Korean intruders. Most tourist and media photos of the "Demilitarised Zone fence" are actually of the CCL fence.
p53 Also Tumor protein P53 (TP53), transformation-related protein 53 (TRP53), and cellular tumor antigen p53. A class of regulatory proteins encoded by the TP53 gene in vertebrates which bind DNA and regulate gene expression in order to protect the genome from mutation and block progression through the cell cycle if DNA damage does occur. It is mutated in more than 50% of human cancers, indicating it plays a crucial role in preventing cancer formation.
=== Addition to alkenes and alkynes === The Hg2+ center binds to alkenes, inducing the addition of hydroxide and alkoxide. For example, treatment of methyl acrylate with mercuric acetate in methanol gives an α-mercuri ester:
Sources: en.wikipedia.org
ago. A more correct treatment would require the use of delay differential equations. Latent period is the transition time between contagion event and disease manifestation. In cases of diseases with varying latent periods, the basic reproduction number can be calculated as the sum of the reproduction numbers for each transition time into the disease. An example of this is tuberculosis (TB). Blower and coauthors calculated from a simple model of TB the following reproduction number:
20 February Reg Douglas, Olympic rower (1956), British Empire and Commonwealth Games gold (1954, 1958) and silver medallist (1954) (born 1930). Sir Peter Trapski, lawyer and judge, chief District Court judge (1985–1989) (born 1935). Maata Wharehoka, weaver, Māori arts advocate, community leader (Parihaka), Ngā Tohu ā Tā Kīngi Īhaka (2015) (born 1950). 21 February – John Anderson, businessman, founder of Contiki Tours (1962) (born 1938). 24 February – Khalid Sandhu, Muslim community leader and physician, president of the Federation of Islamic Associations of New Zealand (1986–1988, 1989–1990) (born 1942). 27 February Dave Gillespie, rugby union player (Otago, Wellington, national team) (born 1934). Michael Moroney, Hall of Fame Thoroughbred racehorse trainer (Brew, Tofane, Xcellent) (born 1958).
One chromatography technique based on molecular properties is usually not sufficient in obtaining a protein of high purity. In addition to size, ion exchange chromatography separates compounds according to the nature and degree of their ionic charge. The column to be used is selected according to its type and strength of charge. Anion exchange resins have a positive charge and are used to retain and separate negatively charged compounds (anions), while cation exchange resins have a negative charge and are used to separate positively charged molecules (cations). Before the separation begins a buffer is pumped through the column to equilibrate the opposing charged ions. Upon injection of the sample, solute molecules will exchange with the buffer ions as each competes for the binding sites on the resin. The length of retention for each solute depends upon the strength of its charge. The most weakly charged compounds will elute first, followed by those with successively stronger charges. Because of the nature of the separating mechanism, pH, buffer type, buffer concentration, and temperature all play important roles in controlling the separation. Ion exchange chromatography is a very powerful tool for use in protein purification and is frequently used in both analytical and preparative separations. It is especially useful when purifying nucleic-acid binding proteins, where separation of the protein from the bound nucleic acid is required to obtain a pure sample devoid of nucleic acids co-purified from the expression system or the native source.
Constancy testing is the verification of reference values as part of quality assurance in x-ray diagnostics, nuclear medicine diagnostics, and radiotherapy. National regulations specify which parameters are to be tested, which limits are to be observed, which test methods are to be used, and which test samples are to be used. In Germany, the Radiation Protection in Medicine Directive and the relevant DIN 6855 standard in nuclear medicine require regular (in some cases daily) constancy testing. Test sources are used to check the response of probe measuring stations as well as in vivo and in vitro measuring stations. Before starting the tests, the background count rate and the setting of the energy window must be checked every working day, and the settings and the yield with reproducible geometry must be checked at least once a week with a suitable test source, e.g. 137Caesium (DIN 6855-1). The reference values for the constancy test are determined during the acceptance test. Compact test specimens for medical X-ray images were not created until 1982. Prior to this, the patient himself often served as the object for producing X-ray test images. Prototypes of such an X-ray phantom with integrated structures were developed by Thomas Bronder at the Physikalisch-Technische Bundesanstalt. A water phantom is a Plexiglas container filled with distilled water that is used as a substitute for living tissue to test electron linear accelerators used in radiation therapy.
Sources: en.wikipedia.org
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.
No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.
Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.